|
π¬
|
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine
E. Keyaerts,
L. Vijgen,
P. Maes,
J. Neyts,
M. Ranst
|
9 |
2004 |
9
π¬
|
|
π¦
|
Complete Genomic Sequence of Human Coronavirus OC43: Molecular Clock Analysis Suggests a Relatively Recent Zoonotic Coronavirus Transmission Event
8 auth.
L. Vijgen,
E. Keyaerts,
E. MoeΜs,
I. Thoelen,
E. Wollants,
P. Lemey,
...
A. Vandamme,
M. Van Ranst
|
8 |
2005 |
8
π¦
|
|
π
|
Antiviral Activity of Chloroquine against Human Coronavirus OC43 Infection in Newborn Mice
7 auth.
E. Keyaerts,
Sandra Li,
L. Vijgen,
Evelien Rysman,
J. Verbeeck,
M. Van Ranst,
...
P. Maes
|
8 |
2009 |
8
π
|
|
π
|
Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle
8 auth.
E. Keyaerts,
L. Vijgen,
C. Pannecouque,
E. V. Van Damme,
W. Peumans,
H. Egberink,
...
J. Balzarini,
M. Van Ranst
|
8 |
2007 |
8
π
|
|
π¦
|
Evolutionary History of the Closely Related Group 2 Coronaviruses: Porcine Hemagglutinating Encephalomyelitis Virus, Bovine Coronavirus, and Human Coronavirus OC43
8 auth.
L. Vijgen,
E. Keyaerts,
P. Lemey,
P. Maes,
K. Van Reeth,
H. Nauwynck,
...
M. Pensaert,
M. Van Ranst
|
7 |
2006 |
7
π¦
|
|
π
|
In Vitro Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor TMC435
19 auth.
O. Lenz,
T. Verbinnen,
Tse-i Lin,
L. Vijgen,
M. Cummings,
J. Lindberg,
J. Berke,
P. Dehertogh,
Els Fransen,
A. Scholliers,
...
Katrien Vermeiren,
T. Ivens,
P. Raboisson,
M. Edlund,
Susan Storm,
L. Vrang,
Herman A de Kock,
G. Fanning,
K. Simmen
|
7 |
2010 |
7
π
|
|
π
|
A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium
10 auth.
E. MoeΜs,
L. Vijgen,
E. Keyaerts,
K. Zlateva,
Sandra Li,
P. Maes,
...
K. PyrΔ,
B. Berkhout,
L. van der Hoek,
M. Van Ranst
|
7 |
2005 |
7
π
|
|
π¬
|
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compoundβ
E. Keyaerts,
L. Vijgen,
Luni Chen,
P. Maes,
G. Hedenstierna,
M. Van Ranst
|
7 |
2004 |
7
π¬
|
|
π
|
Virology analyses of HCV isolates from genotype 1-infected patients treated with simeprevir plus peginterferon/ribavirin in Phase IIb/III studies.
11 auth.
O. Lenz,
T. Verbinnen,
B. Fevery,
L. Tambuyzer,
L. Vijgen,
M. Peeters,
...
A. Buelens,
H. Ceulemans,
M. Beumont,
G. Picchio,
S. De Meyer
|
7 |
2015 |
7
π
|
|
π¬
|
Subgroup Prevalence and Genotype Circulation Patterns of Human Respiratory Syncytial Virus in Belgium during Ten Successive Epidemic Seasons
K. Zlateva,
L. Vijgen,
Nathalie Dekeersmaeker,
Cecilia Naranjo,
M. Van Ranst
|
7 |
2007 |
7
π¬
|
|
π¦
|
Development of One-Step, Real-Time, Quantitative Reverse Transcriptase PCR Assays for Absolute Quantitation of Human Coronaviruses OC43 and 229E
L. Vijgen,
E. Keyaerts,
E. MoeΜs,
P. Maes,
Griet Duson,
M. Van Ranst
|
6 |
2005 |
6
π¦
|
